These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7490364)

  • 21. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
    Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
    J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines.
    Wu Y; Chen X; Ge X; Xia H; Wang Y; Su S; Li W; Yang T; Wei M; Zhang H; Gou L; Li J; Jiang X; Yang J
    J Mol Med (Berl); 2016 Feb; 94(2):195-206. PubMed ID: 26383911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
    Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
    Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α.
    Langkilde A; Olsen LC; Sætrom P; Drabløs F; Besenbacher S; Raaby L; Johansen C; Iversen L
    PLoS One; 2016; 11(12):e0167437. PubMed ID: 28005985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation.
    Gottlieb AB; Grossman RM; Khandke L; Carter DM; Sehgal PB; Fu SM; Granelli-Piperno A; Rivas M; Barazani L; Krueger JG
    J Invest Dermatol; 1992 Mar; 98(3):302-9. PubMed ID: 1372027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network.
    Ockenfels HM; Schultewolter T; Ockenfels G; Funk R; Goos M
    Br J Dermatol; 1998 Sep; 139(3):390-5. PubMed ID: 9767281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
    Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
    Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic effects of topical calcipotriol (MC 903) treatment in psoriatic skin.
    Reichrath J; Müller SM; Kerber A; Baum HP; Bahmer FA
    J Am Acad Dermatol; 1997 Jan; 36(1):19-28. PubMed ID: 8996256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
    Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
    Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis.
    Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L
    Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis.
    Shiohara T; Imanishi K; Sagawa Y; Nagashima M
    J Am Acad Dermatol; 1992 Oct; 27(4):568-74. PubMed ID: 1401309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
    Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
    Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.
    Trepicchio WL; Ozawa M; Walters IB; Kikuchi T; Gilleaudeau P; Bliss JL; Schwertschlag U; Dorner AJ; Krueger JG
    J Clin Invest; 1999 Dec; 104(11):1527-37. PubMed ID: 10587516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
    Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
    J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of interleukin-4 receptors on psoriatic epidermal cells.
    Prens E; Hegmans J; Lien RC; Debets R; Troost R; van Joost T; Benner R
    Am J Pathol; 1996 May; 148(5):1493-502. PubMed ID: 8623919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.
    Toichi E; Torres G; McCormick TS; Chang T; Mascelli MA; Kauffman CL; Aria N; Gottlieb AB; Everitt DE; Frederick B; Pendley CE; Cooper KD
    J Immunol; 2006 Oct; 177(7):4917-26. PubMed ID: 16982934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.
    Nickoloff BJ; Karabin GD; Barker JN; Griffiths CE; Sarma V; Mitra RS; Elder JT; Kunkel SL; Dixit VM
    Am J Pathol; 1991 Jan; 138(1):129-40. PubMed ID: 1702929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.